Literature DB >> 4045253

Pathophysiology of shock and hemorrhage in a fulminating viral infection (Ebola).

S P Fisher-Hoch, G S Platt, G H Neild, T Southee, A Baskerville, R T Raymond, G Lloyd, D I Simpson.   

Abstract

Eleven rhesus monkeys were monitored intensively during experimental infection with Ebola virus. Prominent neutrophilia with left shift and lymphopenia were the earliest abnormalities and were statistically significant by day 4 (P less than .02 and P less than .01, respectively). By day 4 falls in platelet counts were not statistically significant, whereas in vitro platelet aggregation was markedly depressed, progressing rapidly to complete failure by the time of maximum illness. Intraplatelet protein studies suggested this event was the result of in vivo activation and degranulation. Coagulation cascade defects were mainly in the intrinsic system and were surprisingly mild, with no evidence of selective consumption or production deficit of factor VII or VIII. When the possibility of indirectly mediated damage to endothelium possibly by a nonspecific immune response was examined, weight loss was less severe in drug-treated monkeys, and all had detectable plasma prostacyclin metabolites, but there was no improvement in survival.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4045253     DOI: 10.1093/infdis/152.5.887

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  51 in total

1.  Ebola virus selectively inhibits responses to interferons, but not to interleukin-1beta, in endothelial cells.

Authors:  B H Harcourt; A Sanchez; M K Offermann
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

2.  Infection and activation of monocytes by Marburg and Ebola viruses.

Authors:  U Ströher; E West; H Bugany; H D Klenk; H J Schnittler; H Feldmann
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

3.  Dengue hemorrhagic fever-associated immunomediators induced via maturation of dengue virus nonstructural 4B protein in monocytes modulate endothelial cell adhesion molecules and human microvascular endothelial cells permeability.

Authors:  James F Kelley; Pakieli H Kaufusi; Vivek R Nerurkar
Journal:  Virology       Date:  2011-11-29       Impact factor: 3.616

4.  Host response dynamics following lethal infection of rhesus macaques with Zaire ebolavirus.

Authors:  Hideki Ebihara; Barry Rockx; Andrea Marzi; Friederike Feldmann; Elaine Haddock; Douglas Brining; Rachel A LaCasse; Don Gardner; Heinz Feldmann
Journal:  J Infect Dis       Date:  2011-11       Impact factor: 5.226

5.  Advanced antisense therapies for postexposure protection against lethal filovirus infections.

Authors:  Travis K Warren; Kelly L Warfield; Jay Wells; Dana L Swenson; Kelly S Donner; Sean A Van Tongeren; Nicole L Garza; Lian Dong; Dan V Mourich; Stacy Crumley; Donald K Nichols; Patrick L Iversen; Sina Bavari
Journal:  Nat Med       Date:  2010-08-22       Impact factor: 53.440

6.  Enzyme immunosorbent assay for Ebola virus antigens in tissues of infected primates.

Authors:  T G Ksiazek; P E Rollin; P B Jahrling; E Johnson; D W Dalgard; C J Peters
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

7.  Lethal experimental infections of rhesus monkeys by aerosolized Ebola virus.

Authors:  E Johnson; N Jaax; J White; P Jahrling
Journal:  Int J Exp Pathol       Date:  1995-08       Impact factor: 1.925

Review 8.  Ebola virus transmission.

Authors:  W L Irving
Journal:  Int J Exp Pathol       Date:  1995-08       Impact factor: 1.925

9.  Activation of endothelial cells via antibody-enhanced dengue virus infection of peripheral blood monocytes.

Authors:  R Anderson; S Wang; C Osiowy; A C Issekutz
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

10.  Filovirus-induced endothelial leakage triggered by infected monocytes/macrophages.

Authors:  H Feldmann; H Bugany; F Mahner; H D Klenk; D Drenckhahn; H J Schnittler
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.